7-30594959-GC-CT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_002047.4(GARS1):c.38_39delGCinsCT(p.Arg13Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Consequence
GARS1
NM_002047.4 missense
NM_002047.4 missense
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.74
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARS1 | NM_002047.4 | c.38_39delGCinsCT | p.Arg13Pro | missense_variant | ENST00000389266.8 | NP_002038.2 | ||
GARS1 | NM_001316772.1 | c.-125_-124delGCinsCT | 5_prime_UTR_variant | 1/17 | NP_001303701.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.38_39delGCinsCT | p.Arg13Pro | missense_variant | 1 | NM_002047.4 | ENSP00000373918.3 | |||
GARS1 | ENST00000675651.1 | c.38_39delGCinsCT | p.Arg13Pro | missense_variant | ENSP00000502513.1 | |||||
GARS1 | ENST00000675810.1 | c.38_39delGCinsCT | p.Arg13Pro | missense_variant | ENSP00000502743.1 | |||||
GARS1 | ENST00000675693.1 | c.18+20_18+21delGCinsCT | intron_variant | ENSP00000502174.1 | ||||||
GARS1 | ENST00000675051.1 | c.22-3837_22-3836delGCinsCT | intron_variant | ENSP00000502296.1 | ||||||
GARS1 | ENST00000674815.1 | c.-148+7_-148+8delGCinsCT | splice_region_variant, intron_variant | ENSP00000502799.1 | ||||||
GARS1 | ENST00000674851.1 | c.-184+7_-184+8delGCinsCT | splice_region_variant, intron_variant | ENSP00000502451.1 | ||||||
GARS1 | ENST00000444666.6 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.38_39delGCinsCT | non_coding_transcript_exon_variant | 1/16 | ENSP00000502681.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2023 | This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 13 of the GARS protein (p.Arg13Pro). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with GARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 476757). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at